Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects

被引:40
|
作者
Legrain, S [1 ]
Girard, L [1 ]
机构
[1] Grp Hosp Bichat Claude Bernard, Serv Geriatr, F-75877 Paris 18, France
关键词
D O I
10.2165/00002512-200320130-00001
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Man and higher primates have adrenals that secrete large amounts of dehydroepiandrosterone (DHEA) [prasterone] and its sulphate (DHEAS) [PB 008]. A remarkable feature of plasma DHEAS levels in humans is their great decrease with aging. Researchers have postulated that this age-related decline of DHEAS levels may explain some of the degenerative changes associated with aging. Moreover, administration of DHEA to laboratory animals has demonstrable beneficial effects such as prevention of diabetes mellitus, obesity, cancer, heart disease and positive immunomodulator effects. However, in rodents DHEA(S) circulating levels are so low that it is impossible to detect any significant age-related decrease. Therefore results from rodent experiments are not relevant to human beings. Three mechanisms of action of DHEA(S) have been identified.. DHEA and DHEAS are precursors of testosterone and estradiol, DHEAS is a neurosteroid which modulates neuronal excitability via specific interactions with neurotransmitter receptors and DHEA is an activator of calcium-gated potassium channels. Randomised, placebo-controlled clinical trials which included healthy individuals aged 60 years and over treated with (near) physiological doses of DHEA (50-100 mg/day) have yielded very few positive results. Impact of DHEA replacement treatment was assessed on mood, well being, cognitive and sexual functions, bone mass, body composition, vascular risk factors, immune functions and skin. The major limitations of these trials were their short duration (maximum I year) and the low number of study participants involved (maximum 280). Many elderly people in western countries take DHEA without medical supervision. In the US, DHEA is even classified as food supplement. At present there is no scientific evidence to recommend DHEA replacement in the elderly. Further studies are needed to form conclusions about the efficacy and the safety of DHEA replacement in elderly, and to better understand the mechanisms of action of DHEA at the molecular and cellular levels.
引用
收藏
页码:949 / 967
页数:19
相关论文
共 50 条
  • [1] Pharmacology And Therapeutic Effects of Dehydroepiandrosterone In Older Subjects
    Sylvie Legrain
    Laurence Girard
    Drugs & Aging, 2003, 20 : 949 - 967
  • [2] THERAPEUTIC EFFECTS OF DEHYDROEPIANDROSTERONE (DHEA) IN DIABETIC MICE
    COLEMAN, DL
    LEITER, EH
    SCHWIZER, RW
    DIABETES, 1982, 31 (09) : 830 - 833
  • [3] PHARMACOLOGY AND THERAPEUTIC EFFECTS OF MEPIRODIPINE
    SATOH, H
    CARDIOVASCULAR DRUG REVIEWS, 1991, 9 (04): : 340 - 356
  • [4] PHARMACOLOGY AND THERAPEUTIC EFFECTS OF NICORANDIL
    KINOSHITA, M
    SAKAI, K
    CARDIOVASCULAR DRUGS AND THERAPY, 1990, 4 (04) : 1075 - 1088
  • [5] Dehydroepiandrosterone sulfate (DHEA-S) and Alzheimer's dementia in older subjects
    Bo, Mario
    Massaia, Massimiliano
    Zannella, Patrizia
    Cappa, Giorgetta
    Ferrario, Ermanno
    Rainero, Innocenzo
    Arvat, Emanuela
    Giordano, Roberta
    Molaschi, Mario
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 21 (11) : 1065 - 1070
  • [6] Pharmacology and the older person: Effects on communication
    Vogel, D
    Carter, PB
    TOPICS IN GERIATRIC REHABILITATION, 1998, 14 (02) : 76 - 86
  • [7] Dehydroepiandrosterone (DHEA): Pharmacological Effects and Potential Therapeutic Application
    Nenezic, Nemanja
    Kostic, Smiljana
    Strac, Dubravka Svob
    Grunauer, Marija
    Nenezic, Dragana
    Radosavljevic, Milica
    Jancic, Jasna
    Samardzic, Janko
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2023, 23 (08) : 941 - 952
  • [8] Ayahuasca: pharmacology, safety, and therapeutic effects
    dos Santos, Rafael Guimaraes
    Hallak, Jaime Eduardo Cecilio
    CNS SPECTRUMS, 2024,
  • [9] THE ANTIHISTAMINIC DRUGS - PHARMACOLOGY AND THERAPEUTIC EFFECTS
    FEINBERG, SM
    AMERICAN JOURNAL OF MEDICINE, 1947, 3 (05): : 560 - 570
  • [10] DILTIAZEM - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN OLDER PATIENTS
    MARKHAM, A
    BROGDEN, RN
    DRUGS & AGING, 1993, 3 (04) : 363 - 390